These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 12063984

  • 1. Percutaneous ethanol injection under CT fluoroscopy for hypervascular hepatocellular carcinoma following transcatheter arterial embolization.
    Hamuro M, Kaminou T, Nakamura K, Matsuoka T, Sakai Y, Morimoto A, Hayashi S, Nakamura A, Hatagawa M, Yamada R.
    Hepatogastroenterology; 2002; 49(45):752-7. PubMed ID: 12063984
    [Abstract] [Full Text] [Related]

  • 2. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H.
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [Abstract] [Full Text] [Related]

  • 3. Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma.
    Itsubo M, Koike K, Tsuno S, Osada M, Komuro O, Shimada N, Okuda J, Fukada H, Okuaki Y, Kawabe T, Toda G.
    Hepatogastroenterology; 2002; 49(45):735-9. PubMed ID: 12063981
    [Abstract] [Full Text] [Related]

  • 4. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H, Okada S, Okusaka T, Ikeda M, Tanaka N, Sakamoto M, Yoshimori M.
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 6. Transcatheter arterial embolization and extrabeam radiation therapy for subcutaneous seeding of hepatocellular carcinoma by percutaneous ethanol injection.
    Yamanaka T, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Takase K, Nakano T.
    Hepatogastroenterology; 2002 Dec; 49(48):1656-8. PubMed ID: 12397757
    [Abstract] [Full Text] [Related]

  • 7. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [Abstract] [Full Text] [Related]

  • 8. [Locoregional treatment of hepatocellular carcinoma: comparison between percutaneous alcohol administration and intraarterial chemoembolization].
    Cioni G, Turrini F, Pedrazzini PG, Cristani A, Ventura E, Ferrari A, D'Alimonte P, Ariosi P, De Santis M.
    Recenti Prog Med; 2002 Jun; 93(6):361-6. PubMed ID: 12085715
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis.
    Kiba T, Numata K, Kitamura T, Morita K, Saito S, Sekihara H.
    Hepatogastroenterology; 2001 Jun; 48(38):427-31. PubMed ID: 11379324
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ, Wu PH, Zhao M, Gu YK, Zhang L, Tan ZB.
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
    [Abstract] [Full Text] [Related]

  • 11. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 12. Intraperitoneal hemorrhage as a major complication of percutaneous ethanol injection therapy for hepatocellular carcinoma.
    Ohmoto K, Kunieda T, Shibata N, Yamamoto S.
    Hepatogastroenterology; 2000 Dec; 47(35):1199-202. PubMed ID: 11100310
    [Abstract] [Full Text] [Related]

  • 13. [Combined therapy with transcatheter chemo-embolization and percutaneous ethanol injection].
    Nakamura H, Hashimoto T, Suyama Y, Akaji H, Inoue K, Sawada S.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1740-3. PubMed ID: 2167646
    [Abstract] [Full Text] [Related]

  • 14. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 Jul; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 16. Subphrenic abscess formation following superselective transcatheter chemoembolization for hepatocellular carcinoma.
    Yokoi Y, Suzuki S, Sakaguchi T, Okumura T, Kurachi K, Konno H, Nakamura S.
    Radiat Med; 2002 Jul; 20(1):45-9. PubMed ID: 12002604
    [Abstract] [Full Text] [Related]

  • 17. [Meta-analysis of the efficacy of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in treating unresectable primary liver cancer].
    Gu GW, Li XC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 31; 89(12):805-9. PubMed ID: 19595117
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma.
    Ebied OM, Federle MP, Carr BI, Pealer KM, Li W, Amesur N, Zajko A.
    Cancer; 2003 Feb 15; 97(4):1042-50. PubMed ID: 12569604
    [Abstract] [Full Text] [Related]

  • 19. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT, Wang BW, Lo GH, Liang HL, Liu SI, Chou NH, Tsai CC, Chen IS, Yeh MH, Chen YC.
    J Am Coll Surg; 2003 Nov 15; 197(5):730-8. PubMed ID: 14585406
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous ethanol injection for hepatocellular carcinoma originating in the caudate lobe.
    Shibata T, Kubo S, Tabuchi T, Maetani Y, Ametani F, Itoh K, Konishi J.
    Hepatogastroenterology; 2000 Nov 15; 47(33):824-7. PubMed ID: 10919039
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.